|
Worldwide Active Pharmaceutical Ingredients Industry to 2026 - Key Drivers, Restraints and Challenges
Thursday, July 16, 2020
DUBLIN, July 8, 2020 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 91 tables and 99 figures, this 190-page report Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
-- Market Structure
-- Growth Drivers
-- Restraints and Challenges
-- Emerging Product Trends & Market Opportunities
-- Porter's Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.
Key Players
-- AbbVie Inc.
-- Astrazeneca
-- Aurobindo Pharma Ltd.
-- Bayer Healthcare
-- Bioniche Animal Health
-- Boehringer Ingelheim
-- Bristol-Myers Squibb
-- Ceva Animal Health, Inc.
-- Elanco Animal Health
-- Eli Lilly and Company
-- F. Hoffmann-La Roche
-- Glaxosmithkline PLC
-- Heska Co.
-- Lonza Group
-- Merck & Co., Inc.
-- Novartis International AG
-- Pfizer, Inc.
-- Ranbaxy Laboratories
-- Sanofi
-- Sun Pharmaceutical Industries Ltd.
Key Topics Covered:
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis
3 Segmentation of Global Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Customer Base
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI
4 Segmentation of Global Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API
5 Segmentation of Global Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications
6 Segmentation of Global Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs
7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2019-2026
7.2 North America Market 2019-2026 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2019-2026 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2026 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2019-2026 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 Rest of World Market 2019-2026 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
-- AbbVie Inc.
-- Astrazeneca
-- Aurobindo Pharma Ltd.
-- Bayer Healthcare
-- Bioniche Animal Health
-- Boehringer Ingelheim
-- Bristol-Myers Squibb
-- Ceva Animal Health, Inc.
-- Elanco Animal Health
-- Eli Lilly and Company
-- F. Hoffmann-La Roche
-- Glaxosmithkline PLC
-- Heska Co.
-- Lonza Group
-- Merck & Co., Inc.
-- Novartis International AG
-- Pfizer, Inc.
-- Ranbaxy Laboratories
-- Sanofi
-- Sun Pharmaceutical Industries Ltd.
9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/4deivc
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/worldwide-active-pharmaceutical-ingredients-industry-to-2026---key-drivers-restraints-and-challenges-301090056.html
SOURCE Research and Markets
|
|
|
|
|
|
 |
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
|
|
AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
|
|
Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
|
|
Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
|
|
Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
|
|
Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
|
|
PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
|
|
IoTeX Publishes MiCA-Compliant Whitepaper for IOTX, Enabling EU-Wide Alignment Under the New Regulatory Framework | Jan 22, 2026
|
|
Paxos Selects Mesh To Enable Trusted Crypto Deposits | Jan 22, 2026
|
|
Gametime Launches "12 Days of Gametime" Holiday Giveaway in Partnership with Barstool Sports | Jan 22, 2026
|
|
|
|
